Literature DB >> 9118765

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study.

L P Lowe1, K Liu, P Greenland, B E Metzger, A R Dyer, J Stamler.   

Abstract

OBJECTIVE: To assess relationships of diabetes and asymptomatic hyperglycemia at baseline to the risk of cardiovascular disease (CVD) and all-cause (ALL) mortality in employed, white and black middle-aged men. RESEARCH DESIGN AND METHODS: A prospective cohort study of 11,554 white men and 666 black men between the ages 35 and 64 from 1967 to 1973 was conducted using data from the Chicago Heart Association (CHA) Detection Project in Industry 22-year mortality follow-up. cox proportional hazards models, adjusted fro age and other CVD risk factors, were used to estimate the relative risk (RR) and the 95% CI of mortality associated with baseline glycemic status.
RESULTS: Age-adjusted baseline prevalence of clinical diabetes was similar in white (3.7%) and black (4.3%) men; asymptomatic hyperglycemia (glucose post-50-g load > or = 11.1 mmol/l) was present in 11.1% of whites and 7.8% of blacks. After controlling for age, lifestyle, and other CVD risk factors, mortality risk was increased among white men with clinical diabetes (CVD: RR 2.51, CI 2.08-3.02; ALL: RR 1.88, CI 1.63-2.17) and asymptomatic hyperglycemia (CVD: RR 1.18, CI 1.01-1.37; ALL: RR 1.24, CI 1.11-1.37), compared with men with postload glucose < 8.9 mmol/l. Risks were similarly, though nonsignificantly (owing to low statistical power), increased among black men with clinical diabetes (CVD: RR 1.60, CI 0.60-4.29; ALL: RR 1.78, CI 0.97-3.25) and asymptomatic hyperglycemia (CVD: RR 1.29, CI 0.61-2.72; ALL: RR 1.37, CI 0.85-2.20).
CONCLUSIONS: Asymptomatic hyperglycemia and clinical diabetes appear to confer increased mortality risk in both white and black men. In addition, mortality risk is increased with increased severity of glycemia. These findings indicate the importance of applying efforts to reduce risk factors and prevent diabetes in both blacks and whites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9118765     DOI: 10.2337/diacare.20.2.163

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  39 in total

Review 1.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

2.  The use of population attributable risk to estimate the impact of prevention and early detection of type 2 diabetes on population-wide mortality risk in US males.

Authors:  K M Narayan; T J Thompson; J P Boyle; G L Beckles; M M Engelgau; F Vinicor; D F Williamson
Journal:  Health Care Manag Sci       Date:  1999-12

Review 3.  Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.

Authors:  Elisabetta Patorno; Elizabeth M Garry; Amanda R Patrick; Sebastian Schneeweiss; Victoria G Gillet; Olesya Zorina; Dorothee B Bartels; John D Seeger
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

Review 4.  Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?

Authors:  Valentine Prat; Bertrand Rozec; Chantal Gauthier; Benjamin Lauzier
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 5.  Preventing diabetes-related morbidity and mortality in the primary care setting.

Authors:  Samuel Dagogo-Jack
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

6.  Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance.

Authors:  Dianna J Magliano; Stefan Söderberg; Paul Z Zimmet; Bendix Cartensen; Beverly Balkau; Vassen Pauvaday; Sudhir Kowlessur; Jaakko Tuomilehto; K George M M Alberti; Jonathan E Shaw
Journal:  Diabetes Care       Date:  2010-06-08       Impact factor: 19.112

7.  Group of signs: a new method to evaluate glycemic variability.

Authors:  Francesco Zaccardi; Paola Di Stefano; Elena Busetto; Marco Orsini Federici; Andrea Manto; Fabio Infusino; Gaetano Antonio Lanza; Dario Pitocco; Giovanni Ghirlanda
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Severity of coronary artery disease and retinal microvascular signs in patients with diagnosed versus undiagnosed diabetes: cross-sectional study.

Authors:  Kevin Phan; Paul Mitchell; Gerald Liew; Adam J Plant; Sarah B Wang; Joshua Xu; Joseph Chiha; Aravinda Thiagalingam; George Burlutsky; Bamini Gopinath
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

9.  Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Jorge Calles-Escandón; Laura C Lovato; Denise G Simons-Morton; David M Kendall; Rodica Pop-Busui; Robert M Cohen; Denise E Bonds; Vivian A Fonseca; Faramarz Ismail-Beigi; Mary Ann Banerji; Alan Failor; Bruce Hamilton
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152

10.  Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast.

Authors:  Masae Sakuma; Hidekazu Arai; Akira Mizuno; Makiko Fukaya; Motoi Matsuura; Hajime Sasaki; Hisami Yamanaka-Okumura; Hironori Yamamoto; Yutaka Taketani; Toshio Doi; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.